Evaluation of 2,3-dihydroimidazo[2,1-b]oxazole and imidazo[2,1-b]oxazole derivatives as chemotherapeutic agents
Imidazo[2,1-b]oxazole and 2,3-dihydroimidazo[2,1-b]oxazole ring systems are commonly employed in therapeutically active molecules. In this article, the authors review the utilization of these core scaffolds as chemotherapeutic agents from 2018 to 2022. These scaffolds possess many important biological activities including antimicrobial and anticancer, among others. This review covers their biological activities and structure-activity relationships. One of the most important drugs in this class of compounds is the antitubercular agent delamanid. In this paper, the compounds structure-activity relationship and preclinical and clinical trial data are thoroughly presented.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Future medicinal chemistry - 15(2023), 20 vom: 10. Okt., Seite 1885-1901 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shahin, Afnan I [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
2,3-dihydroimidazo[2,1-b]oxazole |
|---|
| Anmerkungen: |
Date Completed 07.11.2023 Date Revised 13.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.4155/fmc-2023-0147 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363079815 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363079815 | ||
| 003 | DE-627 | ||
| 005 | 20231226092604.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4155/fmc-2023-0147 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1210.xml |
| 035 | |a (DE-627)NLM363079815 | ||
| 035 | |a (NLM)37814826 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shahin, Afnan I |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Evaluation of 2,3-dihydroimidazo[2,1-b]oxazole and imidazo[2,1-b]oxazole derivatives as chemotherapeutic agents |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.11.2023 | ||
| 500 | |a Date Revised 13.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Imidazo[2,1-b]oxazole and 2,3-dihydroimidazo[2,1-b]oxazole ring systems are commonly employed in therapeutically active molecules. In this article, the authors review the utilization of these core scaffolds as chemotherapeutic agents from 2018 to 2022. These scaffolds possess many important biological activities including antimicrobial and anticancer, among others. This review covers their biological activities and structure-activity relationships. One of the most important drugs in this class of compounds is the antitubercular agent delamanid. In this paper, the compounds structure-activity relationship and preclinical and clinical trial data are thoroughly presented | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a 2,3-dihydroimidazo[2,1-b]oxazole | |
| 650 | 4 | |a anticancer | |
| 650 | 4 | |a antimicrobial | |
| 650 | 4 | |a delamanid | |
| 650 | 4 | |a imidazo[2,1-b]oxazole | |
| 650 | 4 | |a tuberculosis | |
| 650 | 7 | |a Oxazoles |2 NLM | |
| 650 | 7 | |a Antitubercular Agents |2 NLM | |
| 700 | 1 | |a Zaraei, Seyed-Omar |e verfasserin |4 aut | |
| 700 | 1 | |a Alzuraiqi, Shahed |e verfasserin |4 aut | |
| 700 | 1 | |a Abdulateef, Zahaa |e verfasserin |4 aut | |
| 700 | 1 | |a Abbas, Noora E |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Tel, Taleb H |e verfasserin |4 aut | |
| 700 | 1 | |a El-Gamal, Mohammed I |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 15(2023), 20 vom: 10. Okt., Seite 1885-1901 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:20 |g day:10 |g month:10 |g pages:1885-1901 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc-2023-0147 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 20 |b 10 |c 10 |h 1885-1901 | ||